BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

495 related articles for article (PubMed ID: 19690758)

  • 21. Significance of intramammary lymph nodes in the staging of breast cancer: correlation with tumor characteristics and outcome.
    Nassar A; Cohen C; Cotsonis G; Carlson G
    Breast J; 2008; 14(2):147-52. PubMed ID: 18248563
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mammaglobin expression in leukapheresis products is a predictive marker of poor prognosis in women with high-risk breast cancer.
    Ferrucci PF; Rabascio C; Mazzetta C; Cocorocchio E; Agazzi A; Vanazzi A; Cinieri S; Peccatori FA; Paolucci M; Bertolini F; Martinelli G
    Clin Cancer Res; 2004 Sep; 10(18 Pt 1):6039-46. PubMed ID: 15447988
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Loss of FHIT expression in breast cancer is correlated with poor prognostic markers.
    Arun B; Kilic G; Yen C; Foster B; Yardley DA; Gaynor R; Ashfaq R
    Cancer Epidemiol Biomarkers Prev; 2005 Jul; 14(7):1681-5. PubMed ID: 16030101
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Long-term follow-up study of a prospective multicenter sentinel node trial: molecular detection of breast cancer sentinel node metastases.
    Verbanac KM; Min CJ; Mannie AE; Lu J; O'Brien KF; Rosman M; Tafra L;
    Ann Surg Oncol; 2010 Oct; 17 Suppl 3():368-77. PubMed ID: 20853060
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Alteration of cyclin D1 in Chinese patients with breast carcinoma and its correlation with Ki-67, pRb, and p53.
    Guo LL; Gao P; Wu YG; Jian WC; Hao CY; Li H; Lin XY
    Arch Med Res; 2007 Nov; 38(8):846-52. PubMed ID: 17923265
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mammaglobin and CRxA-01 in pleural effusion cytology: potential utility of distinguishing metastatic breast carcinomas from other cytokeratin 7-positive/cytokeratin 20-negative carcinomas.
    Ciampa A; Fanger G; Khan A; Rock KL; Xu B
    Cancer; 2004 Dec; 102(6):368-72. PubMed ID: 15558786
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluation of three mRNA markers for the detection of lymph node metastases.
    Berger J; Mueller-Holzner E; Fiegl H; Marth C; Daxenbichler G
    Anticancer Res; 2006; 26(5B):3855-60. PubMed ID: 17094413
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Angiogenesis as determined by computerised image analysis and the risk of early relapse in women with invasive ductal breast carcinoma.
    Olewniczak S; Chosia M; Kołodziej B; Kwas A; Kram A; Domagała W
    Pol J Pathol; 2003; 54(1):53-9. PubMed ID: 12817881
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Expression and significance of hTERT mRNA in breast carcinoma and its relation to p53].
    Tang F; Gu DH; Wang H; Zhu TF; Zhu HG; Xu ZD; Hu XQ
    Zhonghua Zhong Liu Za Zhi; 2006 Mar; 28(3):192-5. PubMed ID: 16875603
    [TBL] [Abstract][Full Text] [Related]  

  • 30. CD1a down-regulation in primary invasive ductal breast carcinoma may predict regional lymph node invasion and patient outcome.
    La Rocca G; Anzalone R; Corrao S; Magno F; Rappa F; Marasà S; Czarnecka AM; Marasà L; Sergi C; Zummo G; Cappello F
    Histopathology; 2008 Jan; 52(2):203-12. PubMed ID: 18184269
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Assessment of RT-PCR detection of human mammaglobin for the diagnosis of breast cancer derived pleural effusions.
    Roncella S; Ferro P; Bacigalupo B; Dessanti P; Pronzato P; Franceschini MC; Pratticò L; Carletti AM; Canessa PA; Fontana V; Fais F; Pistillo MP; Fedeli F
    Diagn Mol Pathol; 2008 Mar; 17(1):28-33. PubMed ID: 18303409
    [TBL] [Abstract][Full Text] [Related]  

  • 32. M34 actin regulatory protein is a sensitive diagnostic marker for early- and late-stage mammary carcinomas.
    Soriano Z; Pardee JD
    Clin Cancer Res; 2004 Jul; 10(13):4437-43. PubMed ID: 15240534
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The effect of chemotherapy on status of estrogen receptors in primary tumors and lymph node metastases of human ductal breast cancer.
    Koda M; Lenczewski A; Sulkowska M; Kanczuga-Koda L; Wincewicz A; Tomaszewski J; Sulkowski S
    Oncol Rep; 2007 Feb; 17(2):385-91. PubMed ID: 17203178
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluation of a panel of tumor markers for molecular detection of circulating cancer cells in women with suspected breast cancer.
    Reinholz MM; Nibbe A; Jonart LM; Kitzmann K; Suman VJ; Ingle JN; Houghton R; Zehentner B; Roche PC; Lingle WL
    Clin Cancer Res; 2005 May; 11(10):3722-32. PubMed ID: 15897569
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Detection of lymphovascular invasion in early breast cancer by D2-40 (podoplanin): a clinically useful predictor for axillary lymph node metastases.
    Braun M; Flucke U; Debald M; Walgenbach-Bruenagel G; Walgenbach KJ; Höller T; Pölcher M; Wolfgarten M; Sauerwald A; Keyver-Paik M; Kühr M; Büttner R; Kuhn W
    Breast Cancer Res Treat; 2008 Dec; 112(3):503-11. PubMed ID: 18165897
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sentinel lymph node molecular pathology in breast carcinoma.
    Denninghoff V; Allende D; Paesani F; Garcia A; Avagnina A; Perazzo F; Abalo E; Crimi G; Elsner B
    Diagn Mol Pathol; 2008 Dec; 17(4):214-9. PubMed ID: 18382355
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Detection of Mammaglobin A-mRNA-positive circulating tumor cells in peripheral blood of patients with operable breast cancer with nested RT-PCR.
    Ntoulia M; Stathopoulou A; Ignatiadis M; Malamos N; Mavroudis D; Georgoulias V; Lianidou ES
    Clin Biochem; 2006 Sep; 39(9):879-87. PubMed ID: 16925986
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Decreased expression of annexin A1 is correlated with breast cancer development and progression as determined by a tissue microarray analysis.
    Shen D; Nooraie F; Elshimali Y; Lonsberry V; He J; Bose S; Chia D; Seligson D; Chang HR; Goodglick L
    Hum Pathol; 2006 Dec; 37(12):1583-91. PubMed ID: 16949910
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Omics-based profiling of carcinoma of the breast and matched regional lymph node metastasis.
    Li J; Gromov P; Gromova I; Moreira JM; Timmermans-Wielenga V; Rank F; Wang K; Li S; Li H; Wiuf C; Yang H; Zhang X; Bolund L; Celis JE
    Proteomics; 2008 Dec; 8(23-24):5038-52. PubMed ID: 19003862
    [TBL] [Abstract][Full Text] [Related]  

  • 40. HYOU1/Orp150 expression in breast cancer.
    Stojadinovic A; Hooke JA; Shriver CD; Nissan A; Kovatich AJ; Kao TC; Ponniah S; Peoples GE; Moroni M
    Med Sci Monit; 2007 Nov; 13(11):BR231-239. PubMed ID: 17968289
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.